This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alacrita Launches 2012 Charity Auction Of One-to-One Lunches With Senior Executives From The Pharmaceutical Industry

CAMBRIDGE, Massachusetts and LONDON, December 4, 2012 /PRNewswire/ --

Life Sciences Seasonal Appeal to Raise Funds for WaterAid

Alacrita, the transatlantic firm which is changing the face of life science consulting, is delighted to launch its 2012 Life Sciences Seasonal Appeal. Alacrita is offering the unique opportunity for individuals from the life sciences industry to bid for a two-hour, one-to-one lunch with senior executives from the pharmaceutical industry.

The Appeal aims to raise money for WaterAid ( http://www.wateraid.org), an international non-profit organization that  transforms the lives of people in the world's poorest countries by improving access to safe water and sanitation. Bidding is open from Monday 3 rd December and closes on Thursday 13 th December and details are available on the Alacrita website.

Senior figures from the pharmaceutical industry who have kindly donated their time to the appeal include:

  • Heather Bell , Head of Corporate Strategy and Shaun Grady , Head of Business Development at AstraZeneca
  • Moncef Slaoui , Chairman, Research & Development at GlaxoSmithKline
  • Douglas Giordano , Senior Vice President, Worldwide Business Development at Pfizer
  • Susan Silbermann, President and General Manager, Vaccines, Specialty Care Business Unit and Polly Murphy Vice President, Specialty Care Business Unit Business Development at Pfizer
  • Graham Brazier , Vice President, Business Development, Strategic Transactions Group at Bristol-Myers Squibb
  • Pamela Demain, Executive Director, Corporate Licensing at Merck
  • Susan Jane Herbert , Executive Vice President and Head of Global Business Development and Strategy and Annalisa Jenkins , Executive Vice President and Head of Global Drug Development & Medical and Belen Garijo , Executive Vice President and Chief Operating Officer at Merck Serono

Bidding on the Alacrita auctions will be open until 13 th December, 5pm EST/ 10pm GMT.

Rob Johnson, Partner at Alacrita, said: "We are thrilled to launch this year's seasonal appeal to raise funds for WaterAid. 783 million people, or one in ten of the world's population, live without access to safe water and last year WaterAid reached 1.6 million people with water and 1.9 million people with sanitation in 27 countries. This extremely worthwhile charity has made a significant positive impact on the lives of many people around the world and we are delighted to support its tremendous work. We are also hugely appreciative to the influential industry figures who are donating their time to the appeal. The auction provides the opportunity to spend a couple of hours over lunch building relationships with key pharma decision makers, gaining valuable insights into what science excites them."

David Winder, CEO of  WaterAid ,  America,  added: "We are delighted that Alacrita has chosen to  donate the proceeds of their charity auction to  WaterAid.  Every day, 2,000 children die from water-related diseases that could easily be prevented.  The funds raised will help us reach more of the world's poorest people with safe, clean water and sanitation.  These vital basic services are essential for saving  lives, improving health and reducing poverty in the world's poorest countries."

Notes to Editors

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,232.02 -53.72 -0.29%
S&P 500 2,126.06 -4.76 -0.22%
NASDAQ 5,089.3620 -1.4320 -0.03%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs